Cornerstone Enterprises, LLC Abb Vie Inc. Transaction History

Cornerstone Enterprises, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$164.99 - $203.87 $2.58 Million - $3.18 Million	-15,621 Closed	0 $0
Q3 2024 Feb 13, 2025	BUY	$163.84 - $199.33 $63,897 - $77,738	390 Added 2.56%	15,621 $3.08 Billion
Q2 2024 Feb 13, 2025	BUY	$154.79 - $180.76 $61,296 - $71,580	396 Added 2.67%	15,231 $2.61 Billion
Q1 2024 Feb 13, 2025	BUY	$159.82 - $182.1 $234,455 - $267,140	1,467 Added 10.97%	14,835 $2.68 Billion
Q4 2023 Feb 10, 2025	BUY	$137.6 - $154.97 $1.84 Million - $2.07 Million	13,368 New	13,368 $2.07 Billion

4,110

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $374B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cornerstone Enterprises, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Enterprises, LLC with notifications on news.